Skip to main content

Find Clinical Trials

Home
Conditions
Polyomavirus Infections

Clinical trial condition

Polyomavirus Infections

Explore clinical trials studying Polyomavirus Infections. Study availability and eligibility vary by location and protocol.

129 public trials 36 recruiting studies

Refine in advanced search Browse all conditions

Polyomavirus Infections trial results

Recruiting

Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab

NCT07387198

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +20 more
Locations: Nationales Centrum für Tumorerkrankungen Heidelberg, Baden-Wurttemberg, Germany

Universitätsklinikum Mannheim Mannheim, Baden-Wurttemberg, Germany

Universitätsklinikum Tübingen Tübingen, Baden-Wurttemberg, Germany

Universitätsklinikum Regensburg Regensburg, Bavaria, Germany

View all 14 locations

View Trial Details

Recruiting

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

NCT05076760

Conditions: Adenocarcinoma, Advanced Cancer, Breast Diseases, +50 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

Duke Cancer Institute Durham, North Carolina, United States

View Trial Details

Recruiting

Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy

NCT05849467

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +21 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

French National Database of Rare Dermatological Cancers

NCT03210935

Conditions: Adenocarcinoma, Adnexal Tumor of Skin, Advanced Basal Cell Carcinoma Requiring Systemic Treatment, +16 more
Locations: CHU Bocage Dijon, France

CH Le Mans Le Mans, France

Centre hospitalier Lyon Sud Pierre-Bénite, Pierre-benite, France

CHU Amiens Picardie Amiens, France

View all 34 locations

View Trial Details

Recruiting

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

NCT06947928

Conditions: Adenocarcinoma, Advanced Or Metastatic Merkel Cell Carcinoma, Carcinoma, +22 more
Locations: USC Norris Comprehensive Cancer Center Los Angeles, California, United States

University of California San Francisco - Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

Stanford Health Care - Skin Cancer Program Stanford, California, United States

University of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States

View all 18 locations

View Trial Details

Recruiting

Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype

NCT06753136

Conditions: Abdominal and/or Peritoneal Localizations, Adenocarcinoma, Carcinoma, +36 more
Locations: Istituto Oncologico Veneto Padova, Italy

View Trial Details

Recruiting

Observational Cohort Study of Chronic Viral Infection in the Central Nervous System

NCT07512518

Conditions: Brain Diseases, Central Nervous System Diseases, Central Nervous System Infections, +16 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers

NCT06223659

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +22 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Recruiting

Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma

NCT05496036

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations: Penn Medicine Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma

NCT06151236

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations: Melanoma Institute Australia Wollstonecraft, New South Wales, Australia

View Trial Details